Fumaric Acid

Fumaric Acid

SCHEMBL6969770

CCc1cscc1C(C)c1c[nH]cn1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ CYP2C19 P33261 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6969783 1.00 MAPT (0.33) MAPTALDH1A1CYP3A4TSHRCYP2C19
Fumaric Acid SCHEMBL6969133 0.85 MAPT (0.43) MAPT
Fumaric Acid SCHEMBL6969125 0.85 MAPT (0.43) MAPT
Fumaric Acid SCHEMBL6964434 0.78 MAPT (0.41) MAPTALDH1A1CYP3A4TSHRCYP2C19
Fumaric Acid SCHEMBL6964446 0.78 MAPT (0.41) MAPTALDH1A1CYP3A4TSHRCYP2C19
Fumaric Acid SCHEMBL6972073 0.75 MAPT (0.35) MAPTALDH1A1KDM4E
Fumaric Acid SCHEMBL6972062 0.75 MAPT (0.35) MAPTALDH1A1KDM4E
Fumaric Acid SCHEMBL6969773 0.74 MAPT (0.34) MAPT
Fumaric Acid SCHEMBL6969787 0.74 MAPT (0.34) MAPT
Fumaric Acid SCHEMBL7809157 0.71 PMP22 (0.32) ALDH1A1CYP3A4TSHRCYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954521-B1 4- (THIEN-3-YL)METHYL] IMIDAZOLE DERIVATIVES HAVING ALPHA2-ADRENOCEPTOR AGONISTIC ACTIVITY ORTHO MCNEIL PHARM INC (US) 2003-05-14 — — EP disclosed
US-5750720-A ALPHA-ADRENORECEPTORS AND CENTRAL NERVOUS SYSTEMS ORTHO PHARMACEUTICAL CORPORATION (US) 1998-05-12 — — US disclosed
Send feedback